In partnership with
August 25, 2025
Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.
Want to first start by thanking and acknowledging today’s sponsors, The Daily Upside and Superhuman AI. Our sponsors help make this content free and support the publication and distribution of this platform. Without them, and of course the journalists covering the stories we share, none of this would be feasible.
The cannabis industry just figured out that Trump listens to Heisman winners more than policy wonks, with Ricky Williams delivering the perfect Schedule III pitch wrapped in border security nationalism while Project Champion builds systematic athlete advocacy that speaks his competition-obsessed language. Meanwhile our economic breakdown reveals how Oklahoma's $10 cartridges expose the massive wealth transfer from efficient operators to regulatory rent-seekers that's about to reverse completely, while Europe forces pharma-grade compliance that eliminates smaller operators and THC beverages steal talent from beer giants.
🏈 Track athlete advocacy.
🔬 Monitor EU compliance.
📧 Forward to your board.
Start smarter. Move faster. Stay ahead.
Smart Investors Don’t Guess. They Read The Daily Upside.
Markets are moving faster than ever — but so is the noise. Between clickbait headlines, empty hot takes, and AI-fueled hype cycles, it’s harder than ever to separate what matters from what doesn’t.
That’s where The Daily Upside comes in. Written by former bankers and veteran journalists, it brings sharp, actionable insights on markets, business, and the economy — the stories that actually move money and shape decisions.
That’s why over 1 million readers, including CFOs, portfolio managers, and executives from Wall Street to Main Street, rely on The Daily Upside to cut through the noise.
No fluff. No filler. Just clarity that helps you stay ahead.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Former NFL star Ricky Williams just delivered the most strategically crafted cannabis pitch any president will receive, wrapping his decades-long advocacy journey in border security rhetoric that hits every Trump talking point while leveraging the president's well-documented athlete obsession. Williams, whose cannabis healing story began during his playing career and evolved into Project Champion leadership alongside other athlete advocates, published a USA Today op-ed reframing Schedule 3 rescheduling as economic nationalism that would kneecap Chinese-Mexican "super cartels" laundering money through black-market operations. The Heisman winner's argument connects legal cannabis markets to strengthening borders, creating jobs, and supporting veterans while weakening foreign criminal networks - giving Trump political cover to embrace reform without appearing soft on crime. Williams represents the evolution from individual advocacy to institutional athlete leadership, building coalitions that create policy pressure beyond personal testimony. The timing coincides with Trump's promise to decide on rescheduling "within weeks," while the president continues his pattern of seeking validation from sports figures whether at UFC matches in Vegas, circling Daytona 500 tracks, or attending Super Bowls.
💡 Why It Matters: Athlete advocates possess unique political currency that transcends partisan cannabis debates because Trump actually listens to people who won championships instead of policy wonks who can't throw a spiral. Williams cracked something traditional lobbying couldn't touch by speaking Trump's language of winning, American strength, and foreign threats rather than medical access and social justice. The athlete advocacy model works because sports figures command respect across political divides while their personal healing narratives cut through decades of Drug War conditioning that makes suburban voters nervous about cannabis reform. Project Champion's expansion beyond Williams signals coordinated athlete engagement targeting Trump's documented sports celebrity worship, creating systematic pressure through figures he actually respects rather than advocates he ignores. While cannabis lobbyists spent years crafting policy papers nobody reads, Williams figured out that Trump responds to people who understand competition and built his pitch around cartels versus American business rather than prohibition versus freedom.
🧠 THC Group Take: The cannabis industry just discovered its most powerful lobbying force operates out of locker rooms instead of K Street, because Trump would rather take advice from Super Bowl winners than Harvard policy graduates. Williams proved that athletic credibility cuts through political noise where traditional advocacy fails, turning cannabis reform into border security patriotism that even MAGA conservatives can't easily dismiss. Cannabis companies should immediately prioritize athlete partnerships over traditional lobbying because Trump's sports obsession creates direct access to presidential decision-making that bypasses every conventional political gatekeeper. The Project Champion model represents systematic athlete advocacy that scales beyond celebrity endorsements into institutional pressure, building coordinated campaigns through figures Trump actually admires rather than policy experts he ignores. When the president sees his sports heroes supporting cannabis reform, policy becomes personal validation rather than political calculation - and that's the kind of leverage money can't buy but championships can deliver.
Fast-moving headlines, flagged for what matters.
Minnesota cannabis retailers have permits but no product to sell, proving critics right about the state's backwards market sequencing. Licensed stores like Fridley Dispensary are burning cash while waiting for cultivators who only received permits in late June to complete 90-day grow cycles, with tribal operators prioritizing their own dispensaries before serving the broader market. State regulators ignored industry warnings about supply shortages, with attorney Jason Tarasek telling legislators in April that "we're going to be a bit behind" if cultivation didn't start before rulemaking finished. The Office of Cannabis Management's original timeline assumed cultivators could magically produce cannabis immediately upon licensing, despite basic agricultural reality requiring months from seed to sale. Store owner Jen Swanson captures the financial pain: "By the time we open, we're going to be so far in the hole, it's going to take a while to climb out." Minnesota joins the growing list of states learning that cannabis market launches require actual operational logic, not just regulatory wishful thinking. (MJBizDaily)
Alabama Senator Tommy Tuberville says he's "confident" psychedelics access will expand for veterans under Trump, citing direct conversations with vets who've traveled abroad for ibogaine and other treatments. The Republican senator disclosed that veterans "come to my office quite often" describing overseas psychedelic therapy success, while VA Secretary Doug Collins and HHS Secretary RFK Jr. coordinate research expansion with about a dozen clinical trials underway. VA official Ilse Wiechers confirmed the agency is "exploring the therapeutic potential" of MDMA and psilocybin for PTSD and depression, though emphasized treatments would be clinic-administered like ketamine rather than take-home medications. Tuberville's positioning matters beyond federal policy - he's eyeing Alabama's governor's mansion, where his psychedelics advocacy could establish statewide treatment protocols. His Trump loyalty and veteran-focused messaging create a blueprint for red-state psychedelics acceptance that sidesteps culture war framing entirely, potentially accelerating conservative state adoption faster than traditional drug policy reform. (Marijuana Moment)
Virginia lawmakers are racing to perfect cannabis retail legislation before Governor Youngkin's term ends, but their work could be meaningless if Republicans win in November. A legislative commission is tweaking tax rates and equity provisions after Youngkin vetoed retail market bills twice, with Democrats pushing for lower initial tax rates to compete against illicit sales while debating revenue allocation between equity loans and community reinvestment. The political reality is stark - Democratic candidate Abigail Spanberger supports creating a retail market while Republican Winsome Earle-Sears won't even comment on her position. Small business advocates warn that most cannabis operators nationwide aren't profitable and Virginia's regulatory framework needs to account for economic reality. The commission's summer work essentially amounts to drafting legislation for whichever party controls Richmond come January, making November's gubernatorial race the real determinant of Virginia's cannabis market timeline. (WTVR)
Maryland Governor Wes Moore jokes that marijuana legalization was "the one thing that beat me on the ballot" in 2022, wondering aloud "who is cannabis and how are they so popular?" before turning that voter preference into the smartest criminal justice play any governor has made. Moore realized the obvious contradiction - you can't celebrate a billion-dollar legal market while people can't get barber licenses because of 1990s weed busts - so he dropped the largest mass pardon in US history on 175,000 marijuana convictions. The governor followed up with another 7,000 pardons on Juneteenth and signed automatic record shielding legislation, because apparently he actually listens when voters tell him what they want. Moore's approach puts other Democratic governors to shame by matching policy implementation to ballot box reality instead of just celebrating tax revenue while former offenders stay locked out of legitimate opportunities. His billion-dollar market paired with mass pardons proves you can have both economic success and criminal justice reform if you're not too politically cowardly to connect the dots between past criminalization and present profits. (Marijuana Moment)
THC drinks just proved cannabis can compete in mainstream beverage markets, with $141 million in retail sales while Uncle Arnie's raised $7.5 million by poaching executives from AB InBev and Diageo who see the writing on the wall. The 2018 Farm Bill accidentally created a regulatory loophole allowing hemp-derived THC beverages under 0.3% to sell everywhere - gas stations, grocery stores, delivery apps - regardless of state cannabis laws, making this the first cannabis category to achieve true national distribution. Uncle Arnie's projects 100% annual growth through 2026 while hiring former AB InBev veteran Brian Miesieski as Chief Marketing Officer, because nothing says "we're serious about taking market share" like stealing talent from beer giants. Meanwhile Snoop Dogg launches premium functional beverages and Cookies enters tequila, proving cannabis brands understand they're not just competing for stoner dollars anymore - they're going after Friday night. The beverage alcohol industry should be terrified because THC drinks offer the social lubrication without the hangover, operating under two regulatory frameworks that let them play in both dispensaries and mainstream retail simultaneously. (Sechat)
Multiple research houses are publishing wildly divergent medical cannabis market projections, creating strategic positioning opportunities for institutional players who can navigate the data noise. Towards Healthcare projects 13.8% CAGR reaching $52.23 billion by 2034, while Precedence Research forecasts the broader legal marijuana market hitting $251.51 billion by 2034 at 22.16% CAGR, with medical representing 69% of current demand. The wide variance in methodologies reflects market immaturity and suggests established players can capitalize on analyst uncertainty. Asia Pacific emerges as the fastest-growing region despite North America's dominance, while neurological applications show 13% patient adoption rates in Parkinson's specifically, indicating specialized treatment protocols are gaining clinical traction beyond epilepsy's established beachhead. (Towards Healthcare, Precedence Research)
The Republican establishment just handed its keys to someone who gets high in Vegas and thinks homegrow should be as normal as brewing beer. Florida Senator Joe Gruters won RNC chairmanship with Trump's backing despite Ron DeSantis literally saying he wouldn't appoint Gruters "if George Washington rose from the dead" because of his cannabis advocacy (Marijuana Moment). Gruters campaigned for Florida's failed Amendment 3, sponsored medical marijuana homegrow bills, and openly discussed trying gummies on vacation while admitting "everybody was looking at me" and demanding his wife get him back to their hotel room. The appointment matters because Republican voters already support cannabis reform more than party leadership acknowledges - Trump's own pollster found GOP voters more supportive of state marijuana rights than average Americans. Cannabis companies now have a legalization advocate running Republican ground operations, fundamentally shifting institutional dynamics around federal reform conversations. (Marijuana Moment)
The European Medicines Agency just told the cannabis industry that flower products don't meet medicine standards while simultaneously raising the compliance bar so high that only pharmaceutical-grade operators will survive. The herbal committee concluded no EU monograph can be created for cannabis flowers due to "lack of evidence," finding no authorized medicines made exclusively from cannabis flowers despite formulations existing in individual member states. This bureaucratic rejection arrives alongside new Good Agricultural and Collection Practices rules that blur GACP-GMP boundaries and require full validation from "day one" within six months of publication. Industry analyst Karina Lahnakoski warns companies must reassess suppliers and invest in infrastructure upgrades to meet pharmaceutical-grade standards covering everything from seed source to harvest date traceability. The regulatory squeeze creates intentional market stratification - Europe is essentially saying cannabis can be medicine, but only if you operate like Pfizer. Smaller cultivators and legacy operators get pushed out while institutional players with deep compliance budgets capture the medical market, accelerating cannabis industry consolidation through regulatory capture rather than consumer choice. (Business of Cannabis)
Start learning AI in 2025
Keeping up with AI is hard – we get it!
That’s why over 1M professionals read Superhuman AI to stay ahead.
Get daily AI news, tools, and tutorials
Learn new AI skills you can use at work in 3 mins a day
Become 10X more productive
The deeper pattern behind today’s moves — and why it matters next.
🧾 Context: American cannabis economics make no sense, and Oklahoma proves it. While Minnesota retailers sit with permits but zero product to sell, Oklahoma wholesalers dump concentrate cartridges for under $10 because they're drowning in a 64-to-1 supply glut. New Jersey maintains wholesale prices above $2,500 per pound while Oregon warehouses 3 million pounds of unsold cannabis at $100-300 per pound - a price spread that exists purely because federal law treats cannabis like it's 1920 and state borders are international boundaries (The Oklahoman). The production math is straightforward: outdoor costs $200-300 per pound, greenhouse $300-600, indoor $400-800, but these efficiencies can't scale nationally because multistate operators must build "legally-distinct business entities" in every state instead of just shipping products like normal businesses. Curaleaf operates in 19 states through duplicative facilities rather than centralized production, burning capital on regulatory theater while Oklahoma farmers sell below production costs and Minnesota customers wait months for overpriced flower.
🔎 What It Signals: Economic insanity forces a $50+ billion industry to operate like medieval guilds where every village makes its own everything. Cannabis companies can't leverage basic economies of scale because federal prohibition treats state-to-state commerce like international smuggling, forcing MSOs to replicate entire supply chains in markets where they have no competitive advantage. UCLA research shows multi-store cannabis chains achieve significantly lower pricing through scale, but interstate restrictions prevent these efficiencies from operating nationally, creating artificial scarcity in emerging markets while established markets face price collapse. The Reason Foundation confirms these restrictions violate basic constitutional commerce principles, while academic modeling projects federal legalization with interstate commerce would immediately eliminate regional price premiums and trigger industry consolidation. Cannabis operates as if California agriculture couldn't ship to New York, forcing inefficient local production regardless of climate, costs, or comparative advantage.
🧠 THC Group Take: Here's what everyone's missing: the cannabis industry's current structure is a massive wealth transfer from efficient operators to regulatory rent-seekers, and it's about to reverse completely. While other analysts obsess over quarterly earnings and license counts, the real play is identifying which companies are building for post-prohibition economics versus those milking artificial scarcity. Oklahoma's rock-bottom pricing reveals the industry's true cost structure once regulatory protection disappears - and every MSO trading on limited-license premiums becomes a stranded asset the moment interstate commerce opens. The smart institutional money isn't chasing regulatory arbitrage anymore; it's backing vertically integrated operators with genuine competitive moats in optimal growing regions who can serve national markets efficiently. Companies betting their entire strategy on keeping California flower out of New Jersey are making the same mistake as taxi medallion owners who thought Uber was just a temporary nuisance. Federal normalization won't be gradual - it will be binary, immediate, and devastating to anyone positioned for the old game instead of the new one.
From the hearing room to the comment section — we’re watching it all.
🏨 Florida medical marijuana patients discover hotel stays mean going dry, despite nearly one million registered patients statewide. Amendment 2's "private property only" language means even smoking rooms are off-limits for cannabis, leaving travelers hunting for scarce 420-friendly rentals on platforms like Bud and Breakfast while risking fines for balcony sessions. (Folio Weekly)
👮♂️ Law enforcement claims cannabis legalization lets them focus on "serious crimes" while redirecting resources toward regulatory oversight, but measuring cannabis impairment remains scientifically problematic and the patchwork of state laws creates enforcement chaos that benefits nobody. Colorado's $2 billion in cannabis tax revenue since 2014 sounds impressive until you consider the administrative costs and whether police departments actually got better at solving violent crimes or just found new bureaucratic tasks. (NUG Magazine)
👩👧👦 Cannabis moms are claiming parental space online, with influencers like "Blunt Blowin' Mama" building communities around the mantra "Moms who smoke weed are not bad moms." Edie Parker founder Brett Heyman treats cannabis conversations with her kids like alcohol discussions, but still faces playground judgment after New York Times coverage prompted another parent to voice disapproval of her business. (Business Insider)
🎭 Bill Maher jokes Trump "finally got to me" after suggesting the former president might legalize cannabis, blaming Democrats for consistently "running away from popular issues" like marijuana reform and handing electoral advantages to Republicans who show more political skill at selling important policies. (The Wrap)
📱 Cannabis regulators should steal betting site UX tricks to fix terrible product disclosure design, using icons and plain language instead of legal jargon that requires a law degree to decode. When stakes are high, clarity builds trust - just like gamblers need obvious odds before betting. (Cannabis Law Report)
🧬 Cannabis genetic diversity collapses as commercial operations chase fast harvests and high THC numbers, leaving long-flowering varieties that take 14-22 weeks mostly extinct despite their unique effects and chemical complexity. Industry breeding toward uniformity creates biological fragility reminiscent of the 1950s banana collapse, while Hop Latent Viroid thrives in weakened monoculture genetics. Meanwhile, intellectual property systems could finally reward the underground breeders and pioneering cultivators who spent decades developing these genetic treasures, creating royalty streams for the real innovators instead of just the corporations that scaled their work. (High Times)